Bottom line
PINK vs QAAGZX: the short answer
PINK (Simplify Health Care ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 41% by weight.
But QAAGZX is far broader, holding 277 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.
PINK is cheaper at 0.51% vs 0.86% — a difference of $35 a year per $10,000 invested.
Over one year, PINK returned +24.1% vs +18.1% for QAAGZX.
Updated Nov 19, 2026
PINK vs QAAGZX side by side
| PINK | QAAGZX | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Simplify Exchange Traded | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.51% | 0.86% |
| Annual cost per $10k | $51 | $86 |
| 10-yr cost on $10k (prospectus) | $641 | $1,061 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +24.1% | +18.1% |
| 5-yr return (annualized) | — | +4.1% |
| 10-yr return (annualized) | — | +9.0% |
| Best quarter | +15.6% | +23.4% |
| Worst quarter | −9.5% | −15.8% |
| Net assets (fund) | $358.6M | $751.7M |
| Number of holdings | 54 | 277 |
| Portfolio turnover | 171% | 65% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PINK | QAAGZX | Difference |
|---|---|---|---|
| 2025 | +24.1% | +18.1% | +6.0% |
| 2024 | +8.9% | +1.7% | +7.2% |
| 2023 | +3.8% | +3.0% | +0.8% |
| 2022 | −4.3% | −12.5% | +8.2% |
Source: Fund prospectus bar charts
Holdings overlap
12 of PINK's top 25 holdings also appear in QAAGZX's top 25.
| Holding | PINK | QAAGZX |
|---|---|---|
| Eli Lilly & Company | 5.91% | 14.06% |
| Unitedhealth Group Inc | 5.76% | 5.88% |
| Johnson & Johnson | 5.45% | 6.64% |
| Abbvie Inc | 4.52% | 5.12% |
| Thermo Fisher Scientific Inc | 3.23% | 2.53% |
| Gilead Sciences Inc | 2.87% | 2.79% |
| Elevance Health Inc | 2.73% | 1.54% |
| Danaher Corp | 2.28% | 1.44% |
| Amgen Inc | 2.12% | 1.80% |
| Cvs Health Corp | 2.01% | 0.93% |
| Cardinal Health Inc | 1.78% | 1.04% |
| Vertex Pharmaceuticals Inc | 1.45% | 2.26% |
Source: SEC Form N-PORT
PINK top 10
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Novo Nordisk A/s — 6.75%
- Eli Lilly & Company — 5.91%
- Unitedhealth Group Inc — 5.76%
- Warby Parker Inc — 5.46%
- Johnson & Johnson — 5.45%
- Jazz Pharmaceuticals Plc — 4.61%
- Abbvie Inc — 4.52%
- Biohaven Ltd — 4.32%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between PINK and QAAGZX?
Which is cheaper, PINK or QAAGZX?
Should I own both PINK and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.